The billion-dollar molecule

The Billion-Dollar Molecule was published in 1994, chronicling the formative years of Vertex Pharmaceuticals, a company founded by Joshua Boger. Barry Werth was granted unprecedented access to the startup’s internal meetings and laboratory processes, providing a fly-on-the-wall account of the high-stakes world of structure-based drug design. The narrative captures a pivotal transition in the pharmaceutical industry as researchers moved away from traditional trial-and-error discovery toward a more methodical, computer-aided approach to drug development.

Werth’s work is widely considered a definitive piece of contemporary business and science journalism. He aimed to demystify the complex chemistry behind protein-based drug discovery while highlighting the intense psychological pressures placed on the scientific team. Upon release, the book was received as a gripping, humanized exploration of the intersection between venture capital and cutting-edge molecular biology, setting a standard for narrative nonfiction regarding corporate scientific innovation.